DRIO (DarioHealth) Tax Expense: $0.14 Mil (TTM As of Mar. 2026)


DRIO DarioHealth Corp DRIO
58 GF Score
Price $7.26
GF Value $7.10
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is DarioHealth Tax Expense?

DarioHealth DRIO +7.85% 58 Tax Expense is $0.14 Mil as of Mar. 2026. GuruFocus rates DRIO with a GF Score™ of 58/100 and a GF Value™ of $7.10 (Fairly Valued). The stock has 4 warning signs investors should review.

DarioHealth's tax expense for the months ended in Mar. 2026 was $0.06 Mil. Its tax expense for the trailing twelve months (TTM) ended in Mar. 2026 was $0.14 Mil.


DarioHealth  (NAS:DRIO) Tax Expense Explanation

In the long run, income before tax and taxable income will likely be more similar than they are in any given period. If the one is less in earlier years, then it will be greater in later years. Deferred taxes will reverse themselves in the long run and in total will zero out, unless there is something like a change in tax rates in the intervening period. A deferred tax payable results from a tax break in the early years and will reverse itself in later years; a deferred tax receivable results from more taxes being paid in early years than the tax expense reported to shareholders and will again reverse itself in later years. The deferred tax amount is computed by estimating the amount and the timing of the reversal and multiplying that by the appropriate tax rates.


DarioHealth Tax Expense Related Terms


DarioHealth Tax Expense Historical Data

* Premium members only.

The historical data trend for DarioHealth's Tax Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DarioHealth Tax Expense Chart

DarioHealth Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Tax Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.03 0.00 0.06 -1.85 0.11

DarioHealth Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Tax Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.00 0.00 0.08 0.06
DRIO
58GF Score
DarioHealth Corp DRIO
Tax Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DarioHealth Tax Expense Calculation

Tax paid by the company. It is computed in by multiplying the income before tax number, as reported to shareholders, by the appropriate tax rate. In reality, the computation is typically considerably more complex due to things such as expenses considered not deductible by taxing authorities ("add backs"), the range of tax rates applicable to various levels of income, different tax rates in different jurisdictions, multiple layers of tax on income, and other issues.

Tax Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.14 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Tax Expense →
What does a Tax Expense of $0.14 Mil mean?
DarioHealth (DRIO) has a Tax Expense of $0.14 Mil as of Mar. 2026. Tax expense is the amount of tax the company pays in an accounting period. View historical data on DarioHealth and its competitors.
Is DarioHealth's Tax Expense too high?
DarioHealth's current Tax Expense is $0.14 Mil. Overall, DarioHealth has a GF Score™ of 58/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does DarioHealth's Tax Expense compare to BEAT and ONMD?
DarioHealth's Tax Expense of $0.14 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tax Expense for a Healthcare Providers & Services company?
A good Tax Expense depends on the Healthcare Providers & Services industry context. However, Tax Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tax Expense mean?
A high Tax Expense can signal that a stock is expensive relative to its fundamentals. Tax expense is the amount of tax the company pays in an accounting period. View historical data on DarioHealth and its competitors. DarioHealth's current Tax Expense is $0.14 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DarioHealth stock overvalued right now?
Based on GuruFocus' analysis, DarioHealth (DRIO) is currently considered Fairly Valued. The stock's GF Value™ is $7.10, compared to a current price of $7.26 — trading 2.2% above its estimated fair value. The current Tax Expense is $0.14 Mil. DarioHealth's overall GF Score™ is 58/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tax Expense calculated?
Tax Expense is calculated from a company's financial statements. For DarioHealth (DRIO), the current Tax Expense is $0.14 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DarioHealth (DRIO) Overvalued in 2026?

Based on GuruFocus' analysis, DarioHealth stock appears to be overvalued. The current stock price of $7.26 is trading 2.2% above its estimated GF Value™ of $7.10. GuruFocus considers DarioHealth to be Fairly Valued.

Key valuation signals for DRIO:

  • Tax Expense: $0.14 Mil
  • GF Value™: $7.10 vs. price of $7.26 (2.2% above fair value)
  • GF Score™: 58/100 with 4 warning signs

No single metric tells the full story. See the DRIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


DarioHealth Business Description

Address 322 West 57th Street, New York, NY, USA, 10019
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.
58GF Score

Get the complete analysis for DRIO

Tax Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.26
Price
$7.10
GF Value